[1] Li Z, Li Z, Zhang L, et al.Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study[J]. BMC Cancer,2018,18(1):63.
[2] Bando E, Yonemura Y, Takeshita Y, et al.Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma[J]. Am J Surg,1999,178(3):256-262.
[3] Jamel S, Markar SR, Malietzis G, et al.Prognostic signi-ficance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis[J]. Gastric Cancer,2018,21(1):10-18.
[4] Virgilio E, Giarnieri E, Giovagnoli M, et al.Gastric cancer cells in peritoneal lavage fluid: A systematic review comparing cytological with molecular detection for diagnosis of peritoneal metastases and prediction of peritoneal recurrences[J]. Anticancer Res,2018,38(3):1255-1262.
[5] Kodera Y, Ito S, Mochizuki Y, et al.Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study[J]. Gastric Cancer,2012,15(3):335-337.
[6] Kano K, Aoyama T, Maezawa Y, et al.The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy[J]. Int J Clin Oncol,2017, 22(5):887-896.
[7] Kodera Y, Yoshida K, Kochi M, et al.A randomized phase Ⅲ study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage Ⅲ gastric cancer (JACCRO GC-07 trial)[J]. J Clin Oncol,2018,36(15_suppl):4007.
[8] Ishigami H, Fujiwara Y, Fukushima R, et al.Phase Ⅲ trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial[J]. J Clin Oncol,2018,36(19):1922-1929.
[9] Kuramoto M, Shimada S, Ikeshima S, et al.Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma[J]. Ann Surg,2009,250(2):242-246.
[10] Zhu ZG, Tang R, Yan M, et al.Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study[J]. Dig Surg,2006,23(1-2):93-102.
[11] Aizawa M, Ishigami H, Yabusaki H, et al.PhaseⅡ study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial[J]. J Clin Oncol,2017,35(4_suppl):96.
